| [1] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179. doi: 10.1016/S0140-6736(13)61903-0
|
| [2] |
Trilianos P, Selaru F, Li Z, et al. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis[J]. Digestion,2014,89(2):165-173. doi: 10.1159/000357445
|
| [3] |
Qian MB, Chen YD, Liang S, et al. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma[J]. Infect Dis Poverty,2012,1(1):4. doi: 10.1186/2049-9957-1-4
|
| [4] |
Rizvi S, Gores GJ. Pathogenesis,diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013,145(6):1215-1229. doi: 10.1053/j.gastro.2013.10.013
|
| [5] |
Malaguarnera G, Paladina I, Giordano M, et al. Serum markers of intrahepatic cholangiocarcinoma[J]. Dis Markers,2013,34(4):219-228. doi: 10.1155/2013/196412
|
| [6] |
Sinakos E, Saenger AK, Keach J, et al. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma[J]. Clin Gastroenterol Hepatol,2011,9(5):434-439. doi: 10.1016/j.cgh.2011.02.007
|
| [7] |
Tamada K, Ushio J, Sugano K. Endoscopic diagnosis of extrahepatic bile duct carcinoma: advances and current limitations[J]. World J Clin Oncol, 2011,2(5):203-216. http://cn.bing.com/academic/profile?id=1880275018&encoded=0&v=paper_preview&mkt=zh-cn
|
| [8] |
Cannon RM, Brock G, Buell JF. Surgical resection for hilar cholangiocarcinoma: experience improves resectability[J]. HPB, 2012,14(2):142-149. doi: 10.1111/j.1477-2574.2011.00419.x
|
| [9] |
Sato H, Nakanuma Y, Kozaka K, et al. Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration[J]. Int J Clin Exp Pathol,2013,6(2):318-322. http://cn.bing.com/academic/profile?id=61195720&encoded=0&v=paper_preview&mkt=zh-cn
|
| [10] |
Friman S. Cholangiocarcinoma: current treatment options[J]. Scand J Surg,2011,100(1):30-34. http://cn.bing.com/academic/profile?id=2343334788&encoded=0&v=paper_preview&mkt=zh-cn
|
| [11] |
Robles R, Sánchez-Bueno F, Ramírez P, et al. Liver transplantation for hilar cholangiocarcinoma[J]. World J Gastroenterol,2013,19(48):9209-9215. doi: 10.3748/wjg.v19.i48.9209
|
| [12] |
Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience[J]. Liver Transpl,2005,11(11):1412-1416. doi: 10.1002/lt.20512
|
| [13] |
Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience[J]. Eur J Surg Oncol,2008,34(7):787-794. doi: 10.1016/j.ejso.2007.10.005
|
| [14] |
Starzl TE, Todo S, Tzakis A, et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies[J]. Ann Surg,1989,210(3):374-385. doi: 10.1097/00000658-198909000-00013
|
| [15] |
Alessiani M, Tzakis A, Todo S, et al. Assessment of five-year experience with abdominal organ cluster transplantation[J]. J Am Coll Surg,1995,180(1):1-9. http://cn.bing.com/academic/profile?id=2109647642&encoded=0&v=paper_preview&mkt=zh-cn
|
| [16] |
Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and livertransplantation for unresectable perihilar cholangiocarcinoma[J]. Transplantation,2006,82(12):1703-1707. doi: 10.1097/01.tp.0000253551.43583.d1
|
| [17] |
Gores GJ, Darwish Murad S, Heimbach JK, et al. Liver transplantation for perihilar cholangiocarcinoma[J]. Dig Dis,2013,31(1):126-129. doi: 10.1159/000347207
|
| [18] |
Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers[J]. Gastroenterology,2012,143(1):88-98. doi: 10.1053/j.gastro.2012.04.008
|
点击查看大图
下载:
